Cited by 2,489Cardiac electrophysiology and arrhythmiasCardiac pacing and defibrillation studiesCardiac Arrhythmias and Treatments

The DOI matches its Crossref record, with a small difference in title or year; 34 of the 34 references it cites were found in a registry or an index.

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Open access

Buxton, Alfred E., Lee, Kerry L., Fisher, John D., Josephson, Mark E., Prystowsky, Eric N., Hafley, Gail·1999·New England Journal of Medicine

DOI 10.1056/nejm199912163412503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might reduce the risk of sudden death. METHODS: We conducted a randomized, controlled trial to test the hypothesis that electrophysiologically guided antiarrhythmic therapy would reduce the risk of sudden death among patients with coronary artery disease, a left ventricular ejection fraction of 40 percent or less, and asymptomatic, unsustained ventricular tachycardia. Patients in whom sustained ventricular tachyarrhythmias were induced by programmed stimulation were randomly assigned to receive either antiarrhythmic therapy, including drugs and implantable defibrillators, as indicated by the results of electrophysiologic testing, or no antiarrhythmic therapy. Angiotensin-converting-enzyme inhibitors and beta-adrenergic-blocking agents were administered if the patients could tolerate them. RESULTS: A total of 704 patients with inducible, sustained ventricular tachyarrhythmias were randomly assigned to treatment groups. Five-year Kaplan-Meier estimates of the incidence of the primary end point of cardiac arrest or death from arrhythmia were 25 percent among those receiving electrophysiologically guided therapy and 32 percent among the patients assigned to no antiarrhythmic therapy (relative risk, 0.73; 95 percent confidence interval, 0.53 to 0.99), representing a reduction in risk of 27 percent). The five-year estimates of overall mortality were 42 percent and 48 percent, respectively (relative risk, 0.80; 95 percent confidence interval, 0.64 to 1.01). The risk of cardiac arrest or death from arrhythmia among the patients who received treatment with defibrillators was significantly lower than that among the patients discharged without receiving defibrillator treatment (relative risk, 0.24; 95 percent confidence interval, 0.13 to 0.45; P<0.001). Neither the rate of cardiac arrest or death from arrhythmia nor the overall mortality rate was lower among the patients assigned to electrophysiologically guided therapy and treated with antiarrhythmic drugs than among the patients assigned to no antiarrhythmic therapy. CONCLUSIONS: Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199912163412503

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
Julian, D. G., CAMM, A. J., Frangin, G., Janse, M. J., Munoz, A., Pj, S., & Simon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09145-3 · Cited by 1,100

Show all 34 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 301–400 of 1,000

Implantable Cardioverter-Defibrillators Have Reduced the Incidence of Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Lethal Arrhythmias
Hulleman, M., Berdowski, J., de Groot, J. R., van Dessel, P. F. H. M., Borleffs, C. J. W., Blom, M. T., Bardai, A., de Cock, C. C., Tan, H. L., Tijssen, J. G. P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.089425 · Cited by 83
QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II
brenyo, A. J., Pietrasik, G. M., Barsheshet, A., Huang, D. T.-C., Polonsky, B., McNitt, S. A., Moss, A. J., & Zaręba, W. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02390.x · Cited by 83
Implantable cardioverter defibrillator (ICD) in children
Eicken, A., Kolb, C., Lange, S., Brodherr-Heberlein, S., Zrenner, B., Schreiber, C., & Hess, J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.048 · Cited by 83
“, in patients at risk for but not having had a serious ventricular arrhythmia) [5–7] and for secondary prevention (after successful resuscitation from a life-threatening arrhythmia) [2–4].”
Background
Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors
Bunch, T. J., Hohnloser, S. H., & Gersh, B. J. (2007) · Circulation · doi:10.1161/circulationaha.106.683235 · Cited by 83
Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations
Barra, S., Providencia, R. A., Paiva, L., Heck, P., & Agarwal, S. (2014) · EP Europace · doi:10.1093/europace/euu296 · Cited by 83
“Average age of patients at the time of study enrolment was between 58–65 years in secondary prevention trials(3) – 5 and 58–66 years in the primary prevention trials.(1,2,6,7) Less than 25% of subjects included in the major clinical ICD trials are estimated to be .”
Background
Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications
Borleffs, C. J. W., Thijssen, J., de Bie, M. K., van Rees, J. B., van Welsenes, G. H., van Erven, L., Bax, J. J., Cannegieter, S. C., & Schalij, M. J. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02780.x · Cited by 82
Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era
Bauer, A., Guzik, P., Barthel, P., Schneider, R., Ulm, K., Watanabe, M., & Schmidt, G. P. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi101 · Cited by 82
Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology
Hauer, R. N. W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2584 · Cited by 82
Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection
Parkash, R., Stevenson, W. G., Epstein, L. M., & Maisel, W. H. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.009 · Cited by 81
Outcomes of Early Risk Stratification and Targeted Implantable Cardioverter-Defibrillator Implantation After ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
Zaman, S. J., Sivagangabalan, G., Narayan, A., Thiagalingam, A., Ross, D. L., & Kovoor, P. (2009) · Circulation · doi:10.1161/circulationaha.108.836791 · Cited by 81
Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms
Theuns, D. A. M. J., Rivero‐Ayerza, M., Boersma, E., & Jordaens, L. J. L. M. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.041 · Cited by 81
Cardiac contractility modulation: a novel approach for the treatment of heart failure
ABI‐SAMRA, F. M., & Gutterman, D. D. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9571-6 · Cited by 84
Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia Trial
Russo, A. M., Stamato, N. J., Lehmann, M. H., Hafley, G. E., Lee, K. L., Pieper, K. S., Buxton, A. E., & MUSTT Investigators (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.04050.x · Cited by 81
Self-citation
Survival in octogenarians receiving implantable defibrillators
Koplan, B. A., Epstein, L. M., Albert, C. M., & Stevenson, W. G. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.008 · Cited by 80
B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias
Levine, Y. C., Rosenberg, M. A., Mittleman, M. A., Samuel, M., Methachittiphan, N., Link, M. S., Josephson, M. E., & Buxton, A. E. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.024 · Cited by 80
Self-citation
Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices
Curtis, A. B., Ellenbogen, K. A., Hammill, S. C., Hayes, D. L., REYNOLDS, D. W., Wilber, D. J., & CAIN, M. E. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.08.003 · Cited by 79
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
Owens, D. K., Sanders, G. D., Heidenreich, P. A., McDonald, K. M., & Hlatky, M. A. (2002) · American Heart Journal · doi:10.1067/mhj.2002.125501 · Cited by 80
Not Everyone With an Ejection Fraction ≤30% Should Receive an ICD
Buxton, A. E. (2005) · Circulation · doi:10.1161/01.cir.0000165057.88551.2c · Cited by 80
Self-citation
Sudden cardiac death in China: current status and future perspectives
Zhang, S. (2015) · EP Europace · doi:10.1093/europace/euv143 · Cited by 79
Prevalence and Incidence of Arrhythmias and Sudden Death in Heart Failure
Cleland, J. G. F., Chattopadhyay, S., Khand, A. U., Houghton, T., & Kaye, G. (2002) · Heart Failure Reviews · doi:10.1023/a:1020024122726 · Cited by 81
“The largest study to have addressed this issue so far, the MUSTT study, suggested that 2 and 5 year all-cause mortality of patients with LVSD subsequent to a myocardial infarction were no different in patients with and without inducible ventricular tachycardia, although there was a 25–30% increased risk of cardiac arr…”
Background
Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%
Thomas, K. L., Al‐Khatib, S. M., Kelsey, R. C., Bush, H., Brosius, L., Velazquez, E. J., Peterson, E. D., & Gilliam, F. R. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.024 · Cited by 78
Clinical Management and Prevention of Sudden Cardiac Death
Yousuf, O. K., Chrispin, J., Tomaselli, G. F., & Berger, R. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.304555 · Cited by 83
Short-Term Exposure to Air Pollution and Cardiac Arrhythmia: A Meta-Analysis and Systematic Review
Song, X., Liu, Y., Hu, Y., Zhao, X., Tian, J., Ding, G., & Wang, S. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13070642 · Cited by 81
QRS Duration Does Not Predict Occurrence of Ventricular Tachyarrhythmias in Patients With Implanted Cardioverter-Defibrillators
Buxton, A. E., Sweeney, M. O., Wathen, M. S., Josephson, M. E., Otterness, M. F., Hogan-Miller, E., Stark, A. J., & DeGroot, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.060 · Cited by 77
Self-citation
A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality
Proietti, R., Labos, C., Davis, M., Thanassoulis, G., Santangeli, P., Russo, V., Biase, L. D., Roux, J.-F., Verma, A., Natale, A., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.11.023 · Cited by 77
Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation
Isaksen, K., Morken, I. M., Munk, P. S., & Larsen, A. I. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711414624 · Cited by 77
Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies
Providencia, R. A., Kramer, D. B., Pimenta, D., Babu, G. G., Hatfield, L. A., Ioannou, A., Novak, J., Hauser, R. G., & Lambiase, P. D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002418 · Cited by 77
Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey
Haugaa, K. H., Tilz, R. R., Bovéda, S., Dobreanu, D., Sciaraffia, E., Mansourati, J., Papiashvili, G., & Dagres, N. (2017) · EP Europace · doi:10.1093/europace/eux089 · Cited by 76
“In patients with ischaemic heart disease, ICD for primary prevention has been shown to be associated with substantial reductions in the rate of sudden cardiac death in several trials.(7,9,10) This EP wire showed that the majority of centres followed the Class I, level of evidence A indications for primary prevention I…”
Background
Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
Lebedev, D. S., Mikhaylov, E. N., Neminuschiy, N. M., Golukhova, E. Z., Babokin, V. E., Bereznitskaya, V. V., Vasichkina, E. S., Garkina, S. V., Sp, G., Davtyan, K. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4600 · Cited by 87
Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials
Yap, Y. G., Duong, T., Bland, M., Malik, M., Torp-Pedersen, C. T., Køber, L., Connolly, S. J., Marchant, B., & Camm, A. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi268 · Cited by 76
Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators
Cygankiewicz, I., Gillespie, J. A., Zaręba, W., Brown, M. W., Goldenberg, I., Klein, H., McNitt, S. A., Polonsky, S., Andrews, M. L., Dwyer, E. M., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.12.023 · Cited by 76
Defibrillation for Ventricular Fibrillation
Nichol, G., Sayre, M. R., Guerra, F., & Poole, J. E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.778 · Cited by 76
Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease
Bello, D. B., Einhorn, A., Kaushal, R., Kenchaiah, S., Raney, A. R., Fieno, D. S., Narula, J., Goldberger, J. J., Shivkumar, K., Subacius, H. P., et al. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.03.031 · Cited by 75
“Patients with CAD and low ejection fractions are candidates for therapy with an implantable cardioverterdefibrillator to prevent sudden cardiac death [2–6].”
Background
Trajectory of End-Stage Heart Failure: The Influence of Technology and Implications for Policy Change
Goldstein, N. E., & Lynn, J. (2006) · Perspectives in biology and medicine · doi:10.1353/pbm.2006.0008 · Cited by 75
Addendum to “Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology” Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society
Epstein, A. E., Baessler, C. A., Curtis, A. B., Estes, N. A. M., Gersh, B. J., Grubb, B. P., & Mitchell, L. B. (2007) · Circulation · doi:10.1161/circulationaha.106.180203 · Cited by 75
Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study
Klein, G. G., Lissel, C., Fuchs, A.-C., Gardiwal, A., Oswald, H., deSousa, M., Pichlmaier, A. M., Lichtinghagen, R., Geerlings, H., Lippolt, P., et al. (2006) · EP Europace · doi:10.1093/europace/eul082 · Cited by 75
Modern Management of Acute Myocardial Infarction
Yang, E. H., Brilakis, E. S., Reeder, G. S., & Gersh, B. J. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2006.08.004 · Cited by 76
Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: Implications for low-voltage cardioversion
Ripplinger, C. M., Lou, Q., Li, W., Hadley, J. L., & Efimov, I. R. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.09.019 · Cited by 74
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation
Colquitt, J. L., Mendes, D., Clegg, A. J., Harris, P., Cooper, K., Picot, J., & Bryant, J. (2014) · Health Technology Assessment · doi:10.3310/hta18560 · Cited by 75
“001).(146) The overall mortality rate at 5 years was 24% among patients who received a defibrillator and 55% among those who did not.”
Background
Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators
Hauser, R. G., Hayes, D. L., Epstein, A. E., Cannom, D. S., Vlay, S. C., SONG, S. L., & Tyers, G. F. O. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.02.011 · Cited by 74
The effects of age on quality of life in implantable cardioverter defibrillator recipients
Hamilton, G. A., & Carroll, D. L. (2004) · Journal of Clinical Nursing · doi:10.1046/j.1365-2702.2003.00846.x · Cited by 74
<![CDATA[Revis�o das II Diretrizes da Sociedade Brasileira de Cardiologia para o Diagn�stico e Tratamento da Insufici�ncia Card�aca]]>
Guimar�es, J. I., Mesquita, E. T., Bocchi, E. A., Vilas-Boas, F., Montera, M. W., Moreira, M. C. V., Batlouni, M., Barretto, A. C. P., Neto, C. D., Mady, C., et al. (2002) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2002001800001 · Cited by 71
Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients
Robin, J. C., Weinberg, K. M., Tiongson, J. E., Carnethon, M. R., Reddy, M., Ciaccio, C. E., Quadrini, M., Hsu, J. C., Fan, J. S., Choi, P., et al. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.06.013 · Cited by 74
Effect of Implantable Defibrillators on Arrhythmic Events and Mortality in the Multicenter Unsustained Tachycardia Trial
Lee, K. L., Hafley, G. E., Fisher, J. D., Gold, M. R., Prystowsky, E. N., Talajic, M. R., Josephson, M. E., Packer, D. L., & Buxton, A. E. (2002) · Circulation · doi:10.1161/01.cir.0000021920.73149.c3 · Cited by 74
Self-citation
Safety and Efficacy of the Subcutaneous Implantable Defibrillator
Lewis, G. F., & Gold, M. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.026 · Cited by 73
Pacemaker and ICD leads: Strategies for long-term management
Borek, P., & Wilkoff, B. L. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9249-7 · Cited by 75
Life-Years Gained From Defibrillator Implantation
Salukhe, T. V., Dimopoulos, K., Sutton, R., Coats, A. J. S., Piepoli, M. F., & Francis, D. P. (2004) · Circulation · doi:10.1161/01.cir.0000125522.10053.29 · Cited by 73
Effect of β-Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)
Ellison, K., Hafley, G. E., Hickey, K. T., Kellen, J., Coromilas, J., Steín, K. M., Lee, K. L., & Buxton, A. E. (2002) · Circulation · doi:10.1161/01.cir.0000038499.22687.39 · Cited by 73
Self-citation
QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias
Kalahasti, V., Nambi, V., Martin, D. O., LAM, C. T., Yamada, D., Wilkoff, B. L., Niebauer, M. J., Jaeger, F. J., TCHOU, P. J., & Chung, M. K. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00886-5 · Cited by 71
Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis
de Sousa, M. R., Morillo, C. A., Rabelo, F. T., Filho, A. M. N., & Ribeiro, A. L. P. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.07.002 · Cited by 72
Do Positive Health Expectations and Optimism Relate to Quality-of-Life Outcomes for the Patient With an Implantable Cardioverter Defibrillator?
Sears, S. F., Serber, E. R., Lewis, T. S., Walker, R. L., Conners, N., Lee, J. T., Curtis, A. B., & Conti, J. B. (2004) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200409000-00008 · Cited by 71
Fighting against sudden cardiac death: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention
Marijon, É., Garcia, R., Narayanan, K., Karam, N., & Jouven, X. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab903 · Cited by 71
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders
Groh, W. J., Bhakta, D., Tomaselli, G. F., Aleong, R. G., Teixeira, R. A., Amato, A. A., Asirvatham, S. J., Cha, Y., Corrado, D., Duboc, D., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.04.022 · Cited by 72
T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy
Rosenthal, T. M., Stahls, P. F., ABI‐SAMRA, F. M., Bernard, M. L., Khatib, S., Polin, G. M., Xue, J. Q., & Morin, D. P. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.04.035 · Cited by 71
“Several prospective, randomized, controlled trials have shown that implantable cardioverterdefibrillator (ICD) placement in these patients reduces mortality.((2-5)) However, in a substantial proportion of patients who receive an ICD based on reduced LVEF, the device never delivers therapy over its lifetime.”
Background
Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction
Sjöblom, J., Muhrbeck, J., Witt, N., Alam, M., & Frykman, V. (2014) · Circulation · doi:10.1161/circulationaha.114.009924 · Cited by 71
Benefit of Primary Prevention Implantable Cardioverter‐Defibrillators in the Setting of Chronic Kidney Disease: A Decision Model Analysis
Amin, M. S., Fox, A. D., Kalahasty, G., Shepard, R. K., Wood, M. A., & Ellenbogen, K. A. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01258.x · Cited by 71
Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes
Santini, M., Ricci, R. P., Lunati, M., Landolina, M., Perego, G. B., Marzegalli, M., Schirru, M., Belvito, C., Brambilla, R., Guenzati, G., et al. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9321-3 · Cited by 71
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and the modelling of cost-effectivenessan cost-utility for these groups in a UK context
Buxton, M. J., Caine, N., Chase, D. P., Connelly, D. T., Grace, A. A., Jackson, C., Parkes, J., & Sharples, L. D. (2006) · Health Technology Assessment · doi:10.3310/hta10270 · Cited by 71
The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
Liu, P. J., Arnold, M., Belenkie, I., Howlett, J. G., Huckell, V. F., Ignazewski, A., LeBlanc, M. H., McKelvie, R. S., Niznick, J., Parker, J. D., et al. (2001) · PubMed · Cited by 71
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004
Al‐Khatib, S. M., Sanders, G. D., Mark, D. B., Lee, K. L., Bardy, G. H., Bigger, J. T., Buxton, A. E., Connolly, S. J., Kadish, A. H., Moss, A. J., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.005 · Cited by 69
Self-citation
Guías de práctica clínica de la Sociedad Española de Cardiología en arritmias cardíacas
Garrote, J. A., Huerta, E. M., Moreno, O. M., Peinado, R., Álvarez, L. P., Granell, R. R., & Viñolas, X. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76313-0 · Cited by 71
Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials
Caldeira, D., David, C., & Sampaio, C. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.11.005 · Cited by 70
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.
Liu, P. X., Arnold, J. M. O., Belenkie, I., Demers, C., Dorian, P., Giannetti, N., Haddad, H. A., Howlett, J. G., Ignazewski, A., Jong, P., et al. (2003) · PubMed · Cited by 69
Current Status of Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter Defibrillator in Patients With Chronic Heart Failure
Satake, H., Fukuda, K., Sakata, Y., Miyata, S., Nakano, M., Kondo, M., Hasebe, Y., Segawa, M., Shimokawa, H., & on behalf of the CHART-2 Investigators (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0925 · Cited by 69
A computer modeling tool for comparing novel ICD electrode orientations in children and adults
Jolley, M. A., Stinstra, J. G., Pieper, S., MacLeod, R., Brooks, D. H., Cecchin, F., & Triedman, J. K. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.01.018 · Cited by 69
Sudden Death Prior to Pediatric Heart Transplantation: Would Implantable Defibrillators Improve Outcome?
Rhee, E. K., Canter, C. E., Basile, S., Webber, S. A., & Naftel, D. C. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.02.005 · Cited by 69
Optimal Programming of Implantable Cardiac-Defibrillators
Madhavan, M., & Friedman, P. A. (2013) · Circulation · doi:10.1161/circulationaha.112.000542 · Cited by 69
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Study protocol
Hohnloser, S. H., Connolly, S. J., Kück, K., Dorian, P., Fain, E. S., Hampton, J., Hatala, R., Pauly, A. C., Roberts, R. S., Themeles, E., et al. (2000) · American Heart Journal · doi:10.1067/mhj.2000.110088 · Cited by 69
Enfermedad cardiovascular en el anciano
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.05.001 · Cited by 72
Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction
Morin, D. P., Saad, M., Shams, O. F., Owen, J. S., Xue, J. Q., ABI‐SAMRA, F. M., Khatib, S., Nelson-Twakor, O. S., & Milani, R. V. (2012) · EP Europace · doi:10.1093/europace/eur426 · Cited by 68
Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT
Sood, N., Ruwald, A., Solomon, S. D., Daubert, J. P., McNitt, S. A., Polonsky, B., Jøns, C., Clyne, C. A., Zaręba, W., & Moss, A. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht451 · Cited by 68
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study
Morin, D. P., Oikarinen, L., Viitasalo, M. T., Toivonen, L., Nieminen, M. S., Kjeldsen, S., Dahlöf, B., John, M., Devereux, R. B., & Okin, P. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp321 · Cited by 67
Time‐Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic Cardiomyopathy
Alsheikh-Ali, A. A. A., HOMER, M., Maddukuri, P. V., Kalsmith, B. M., Estes, N. A. M., & Link, M. S. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01111.x · Cited by 67
Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II–Eligible Population
Chan, P. S., Steín, K. M., Chow, T., Fendrick, M., Bigger, J. T., & Vijan, S. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.051 · Cited by 67
Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome
Furushima, H., Chinushi, M., Sugiura, H., Komura, S., Tanabe, Y., Watanabe, H., Washizuka, T., & Aizawa, Y. (2006) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2005.08.005 · Cited by 68
“Although the effectiveness of catheter ablation for VT has improved [17-20], ICDs have been shown to be highly effective in treating ventricular arrhythmias in patients with coronary heart disease [21,22].”
Background
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.
Tang, A., Ross, H. J., Simpson, C. S., Mitchell, L. B., Dorian, P., Goeree, R. A., Hoffmaster, B., Arnold, M., & Talajic, M. R. (2005) · PubMed · Cited by 65
Amiodarone and Optic Neuropathy: The Heart of the Matter
Murphy, M. A., & Murphy, J. F. (2005) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000177290.09649.38 · Cited by 67
“Implantable cardioverter defibrillators (ICD) are the first-line therapy for both primary and secondary prevention (7,8).”
Background
Expanding Indications for Implantable Cardiac Defibrillators
Bigger, J. T. (2002) · New England Journal of Medicine · doi:10.1056/nejme020011 · Cited by 67
Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes
Sullivan, K., Doumouras, B. S., Santema, B. T., Walsh, M. N., Douglas, P. S., Voors, A. A., & Spall, H. G. C. V. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.12.025 · Cited by 65
ESC Guidelines on Management of Acute Myocardial Infarction in Patients Presenting With Persistent ST-Segment Elevation
de Werf, F. V., Bax, J. J., Betriu, A., Blomström‐Lundqvist, C., Crea, F., Falk, V., Filippatos, G. S., Fox, K. A. A., Huber, K., Kastrati, A., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71559-2 · Cited by 65
Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy
Albert, C. M., Quigg, R. J., Saba, S., Estes, N. A. M., Schaecter, A., Subacius, H. P., Howard, A., Levine, J. H., & Kadish, A. H. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.026 · Cited by 66
Ventricular Arrhythmias and Sudden Cardiac Death in End-Stage Renal Disease Patients on Chronic Hemodialysis
Meier, P., Vogt, P. R., & Blanc, E. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045917 · Cited by 65
“worse than in any other high-risk category, including diabetes mellitus. Calcifying atherosclerotic coronary lesions are common in the HD patient; their presence is related not only to lipid concentrations, but also to the calcium × phosphorus product and probably other factors which are still poorly understood. Thus,…”
Background
The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: A critical reassessment
Billman, G. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.011 · Cited by 69
“Implantable cardioverter defibrillators (ICDs) have been shown to reduce cardiac mortality, providing a better protection from sudden death than current pharmacological therapy in certain high-risk patient populations (Buxton et al., 1999; Connelly et al., 2000; Al-Khatib et al., 2013).”
Background
Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator
Sherazi, S., Daubert, J. P., Block, R., Jeevanantham, V., Abdelgadir, K., DiSalle, M. R., Haley, J. M., & Shah, A. H. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.10.1139 · Cited by 66
Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%
Maury, P., Baratto, F., Zeppenfeld, K., Klein, G. J., Delacrétaz, E., Sacher, F., Pruvot, E. J., Brigadeau, F., Rollin, A., Andronache, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu040 · Cited by 70
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry
Providencia, R. A., Marijon, É., Lambiase, P. D., Bouzeman, A., Defaye, P., Klug, D., Amet, D., Perier, M., Gras, D., Algalarrondo, V., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002756 · Cited by 65
Left Ventricular Mechanical Assist Devices and Cardiac Device Interactions: An Observational Case Series
Foo, D. C. G., WALKER, B. D., Kuchar, D. L., Thorburn, C. W., Tay, A., Hayward, C., Macdonald, P. S., KEOGH, A. M., Kotlyar, E., Spratt, P., et al. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02403.x · Cited by 64
Enhanced Detection of Arrhythmia Vulnerability Using T Wave Alternans, Left Ventricular Ejection Fraction, and Programmed Ventricular Stimulation:
Rashba, E. J., Osman, A., MacMurdy, K., KIRK, M. M., Sarang, S., Peters, R. W., Shorofsky, S. R., & Gold, M. R. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03428.x · Cited by 64
Transient Local Injury Current in Right Ventricular Electrogram After Implantable Cardioverter-Defibrillator Shock Predicts Heart Failure Progression
Tereshchenko, L. G., Faddis, M. N., Fetics, B. J., Zelik, K. E., Efimov, I. R., & Berger, R. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.004 · Cited by 64
Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction
Li, W., Ripplinger, C. M., Lou, Q., & Efimov, I. R. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.03.015 · Cited by 64
Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register
Weeke, P. E., Johansen, J. B., Jørgensen, O. D., Nielsen, J. C., Møller, M. B., Videbæk, R., Hojgaard, M. V., Riahi, S., & Jacobsen, P. K. (2013) · EP Europace · doi:10.1093/europace/eut017 · Cited by 65
Exercise is Superior to Pacing for T Wave Alternans Measurement in Subjects with Chronic Coronary Artery Disease and Left Ventricular Dysfunction
Rashba, E. J., Osman, A., MacMurdy, K., KIRK, M. M., Sarang, S., Peters, R. W., Shorofsky, S. R., & Gold, M. R. (2002) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2002.00845.x · Cited by 64
Year-long upregulation of connexin43 in rabbit hearts by heavy ion irradiation
Amino, M., Yoshioka, K., Fujibayashi, D., Hashida, T., Furusawa, Y., Zaręba, W., Ikari, Y., Tanaka, E., Mori, H., Inokuchi, S., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00160.2009 · Cited by 63
Long-Term Arrhythmia-Free Survival in Patients With Severe Left Ventricular Dysfunction and No Inducible Ventricular Tachycardia After Myocardial Infarction
Zaman, S. J., Narayan, A., Thiagalingam, A., Sivagangabalan, G., Thomas, S. P., Ross, D. L., & Kovoor, P. (2013) · Circulation · doi:10.1161/circulationaha.113.005146 · Cited by 63
“8,9 Inducible ventricular tachycardia (VT) at electrophysiological study (EPS) demonstrates the presence of a substrate for re-entrant tachyarrhythmia and consistently predicts arrhythmia in observational and randomised studies.(10-16) The potential utility of EPS to guide early ICD implantation post-MI has been demon…”
BackgroundMethod
Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy
FREEDBERG, N. A., Hill, J. N., Fogel, R. I., & Prystowsky, E. N. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01226-8 · Cited by 63
Self-citation
Pacing therapies in congestive heart failure II study
Stellbrink, C., Auricchio, A., Butter, C., Sack, S., Vogt, J., Böcker, D., Block, M. S., Kirkels, H., & Misier, A. R. R. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01298-4 · Cited by 63
Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004)
Peinado, R., Arenal, Á., Arribas, F., Torrecilla, E. G., Álvarez, M., Ormaetxe, J. M., & Pérez‐Castellano, N. (2005) · Revista Española de Cardiología · doi:10.1016/s0300-8932(05)74074-4 · Cited by 63
The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients
Tsai, V., Cooper, J. M., Garan, H., Natale, A., Ptaszek, L. M., Ellinor, P. T., Hickey, K. T., Downey, R. A., Zei, P. C., Hsia, H. H., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.814525 · Cited by 62
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0827 · Cited by 68
Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07
Proclemer, A., Ghidina, M., Gregori, D., Facchin, D., Rebellato, L., Fioretti, P., & Brignole, M. (2008) · EP Europace · doi:10.1093/europace/eun370 · Cited by 61

Authors: Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G.
Affiliations: Brown University (US)
Duke University (US)
Albert Einstein College of Medicine (US)
Beth Israel Deaconess Medical Center (US)
ORCID: Buxton, Alfred E.
Lee, Kerry L.
Fisher, John D.
Prystowsky, Eric N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1999-12-16
Volume: 341
Issue: 25
Pages: 1882-1890
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199912163412503
OpenAlex: W2313547185
Cited by: 2,489
References: 34
Citations by year: 2026: 20 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 41 · 2020: 51 · 2019: 54 · 2018: 54 · 2017: 92 · 2016: 75 · 2015: 87 · 2014: 95 · 2013: 114 · 2012: 122
FWCI: 70.29
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5u01hl045726-06)
National Heart, Lung, and Blood Institute (UO1HL45700, UO1-HL45726, U01HL045700)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords: coronary artery disease, asymptomatic ventricular arrhythmia, implantable cardioverter-defibrillator, antiarrhythmic drugs, electrophysiologic testing, programmed electrical stimulation, cardiac arrest, all-cause mortality, left ventricular ejection fraction, ACE inhibitors, beta-blockers
MeSH terms: Aged, Anti-Arrhythmia Agents, Cardiac Pacing, Artificial, Coronary Disease, Electrophysiology, Female, Humans, Male, Middle Aged, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Tachycardia, Ventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks